¼¼°èÀÇ ½Å°æÀçȰ ±â±â ½ÃÀå
Neurorehabilitation Devices
»óǰÄÚµå : 1760890
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 504 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,147,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,443,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½Å°æÀçȰ ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 45¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 18¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½Å°æÀçȰ ±â±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 16.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 45¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½Å°æ ·Îº¿ ½Ã½ºÅÛÀº CAGR 18.7%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 20¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 12.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 5,280¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR21.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½Å°æÀçȰ ±â±â ½ÃÀåÀº 2024³â¿¡ 6¾ï 5,280¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 2,820¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 21.1%·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, °¢°¢ ºÐ¼® ±â°£ Áß¿¡ 12.2%¿Í 16.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.8%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ½Å°æÀçȰ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

½Å°æÀçȰ ±â±â´Â ½Å°æ Àå¾Ö³ª ºÎ»óÀ» ÀÔÀº »ç¶÷µéÀÇ È¸º¹°ú ÀçȰÀ» µ½±â À§ÇØ °í¾ÈµÈ Ư¼ö µµ±¸ÀÔ´Ï´Ù. ÀÌ ÀåºñµéÀº ³úÁ¹Áß, ô¼ö ¼Õ»ó, ¿Ü»ó¼º ³ú¼Õ»ó, ÆÄŲ½¼º´, ´Ù¹ß¼º °æÈ­Áõ°ú °°Àº ½Å°æ ÅðÇ༺ ÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀÇ ¿îµ¿ ±â´É, ÀÎÁö ´É·Â, Àü¹ÝÀûÀÎ »îÀÇ ÁúÀ» °³¼±ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½Å°æÀçȰ ±â±â¿¡´Â ·Îº¿ ¿Ü°ñ°Ý, ³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI), ½Å°æ Àڱرâ, °¡»óÇö½Ç(VR) ±â¹Ý ÀçȰ ½Ã½ºÅÛ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ±â¼úµéÀº Ç¥ÀûÈ­µÈ Ä¡·á¸¦ Á¦°øÇϰí, ¹Ýº¹ ÈÆ·ÃÀ» ¿ëÀÌÇÏ°Ô Çϸç, ÀçȰ °á°ú¸¦ Çâ»ó½Ã۱â À§ÇÑ ½Ç½Ã°£ Çǵå¹éÀ» Á¦°øÇÕ´Ï´Ù.

½Å°æ ÀçȰ ±â±âÀÇ °³¹ß ¹× µµÀÔÀº ½Å°æ°úÇÐ, ·Îº¿ °øÇÐ ¹× µðÁöÅÐ °Ç°­ ±â¼úÀÇ ¹ßÀü¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ·Îº¿ ¿Ü°ñ°Ý°ú º¸Á¶±â±¸´Â ȯÀÚ°¡ ¹Ýº¹ÀûÀÎ ¿îµ¿À» ÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ½Å°æ °¡¼Ò¼º°ú ¿îµ¿ ȸº¹À» ÃËÁøÇϰí, BCI´Â ³ú¿Í ¿ÜºÎ ±â±â °£ÀÇ ¼ÒÅëÀ» ÃËÁøÇÏ¿© ȯÀÚ°¡ ÀÚ½ÅÀÇ ¿òÁ÷ÀÓÀ» Á¦¾îÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. °æµÎ°³ ÀÚ±â ÀÚ±Ø(TMS) ¹× °æµÎ°³ Á÷·ù Àü·ù ÀÚ±Ø(tDCS)°ú °°Àº ½Å°æ ÀÚ±Ø ÀåÄ¡´Â ÀÎÁö ¹× ¿îµ¿ ±â´ÉÀ» °³¼±Çϱâ À§ÇØ ½Å°æ Ȱµ¿À» Á¶ÀýÇϸç, VR ±â¹Ý ½Ã½ºÅÛÀº ÀÎÁö ¹× ½Åü ¿îµ¿À» À§ÇÑ ¸ôÀÔÇü ȯ°æÀ» Á¶¼ºÇÏ¿© ÀçȰÀ» ¸Å·ÂÀûÀ̰í È¿°úÀûÀ¸·Î ¸¸µì´Ï´Ù.

½Å°æÀçȰ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. ù°, ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡, ³úÁ¹Áß ¹× ºÎ»ó »ç·Ê Áõ°¡°¡ Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. µÑ°, ½Å°æ°úÇаú ÀçȰ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ È¿°ú¿Í äÅ÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼Â°, Á¶±â ¹× ÁýÁßÀûÀÎ ÀçȰÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½Å°æÀçȰ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ Çコ ±â¼ú°ú ¿ø°Ý ¸ð´ÏÅ͸µÀÇ ÅëÇÕÀº ÀçȰÀ» ´õ¿í Ä£¼÷ÇÏ°í °³º°È­ µÈ °ÍÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎÀÇ Áö¿ø Á¤Ã¥°ú ½Å°æ ÀçȰ ¿¬±¸ ¹× °³¹ß¿¡ ´ëÇÑ ÀÚ±Ý Áö¿øÀº ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë¿Í Àü¹® ÀçȰ¼¾ÅÍÀÇ °¡¿ë¼º Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(½Å°æ ·Îº¿ ½Ã½ºÅÛ, ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º, ¿þ¾î·¯ºí µð¹ÙÀ̽º, ³úÀÚ±Ø ±â±â), ¿ëµµ(³úÁ¹Áß, ÆÄŲ½¼º´, ³ú ¹× ô¼ö ¼Õ»ó, ³ú¼º¸¶ºñ, ´Ù¹ß¼º °æÈ­Áõ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 105°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è µµ¸ÞÀÎ Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Neurorehabilitation Devices Market to Reach US$4.5 Billion by 2030

The global market for Neurorehabilitation Devices estimated at US$1.8 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2024-2030. Neurorobotic Systems, one of the segments analyzed in the report, is expected to record a 18.7% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Brain Computer Interface segment is estimated at 12.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$652.8 Million While China is Forecast to Grow at 21.1% CAGR

The Neurorehabilitation Devices market in the U.S. is estimated at US$652.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$628.2 Million by the year 2030 trailing a CAGR of 21.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 16.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.

Global Neurorehabilitation Devices Market - Key Trends & Drivers Summarized

Neurorehabilitation devices are specialized tools designed to aid in the recovery and rehabilitation of individuals with neurological disorders and injuries. These devices are used to improve motor function, cognitive abilities, and overall quality of life for patients suffering from conditions such as stroke, spinal cord injuries, traumatic brain injuries, and neurodegenerative diseases like Parkinson’s and multiple sclerosis. Neurorehabilitation devices include robotic exoskeletons, brain-computer interfaces (BCIs), neurostimulation devices, and virtual reality (VR)-based rehabilitation systems. These technologies provide targeted therapy, facilitate repetitive training, and offer real-time feedback to enhance rehabilitation outcomes.

The development and implementation of neurorehabilitation devices are driven by advancements in neuroscience, robotics, and digital health technologies. Robotic exoskeletons and assistive devices enable patients to perform repetitive movements, promoting neuroplasticity and motor recovery. BCIs facilitate communication between the brain and external devices, helping patients regain control over their movements. Neurostimulation devices, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), modulate neural activity to improve cognitive and motor functions. VR-based systems create immersive environments for cognitive and physical exercises, making rehabilitation engaging and effective.

The growth in the neurorehabilitation devices market is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the rising number of stroke and injury cases are significant drivers. Secondly, advancements in neuroscience and rehabilitation technologies are enhancing the effectiveness and adoption of these devices. Thirdly, the growing awareness of the benefits of early and intensive rehabilitation is boosting demand for neurorehabilitation devices. Additionally, the integration of digital health technologies and remote monitoring is making rehabilitation more accessible and personalized. Furthermore, supportive government policies and funding for research and development in neurorehabilitation are encouraging innovation. Lastly, the expansion of healthcare infrastructure and the increasing availability of specialized rehabilitation centers are further driving market growth.

SCOPE OF STUDY:

The report analyzes the Neurorehabilitation Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Neurorobotic Systems, Brain Computer Interface, Wearable Devices, Brain Stimulators); Application (Stroke, Parkinson's Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 105 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â